Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Livopigen ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 4.1%   Bankruptcy risk   30.1% 10.3% 13.2% 6.6% 8.7% 10.5% 21.2% 17.1%   Credit score (0-100)   1 26 19 37 28 22 4 9   Credit rating   C BB BB BBB BB BB B BB   Credit limit (kDKK)   -0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   223 539 908 1,184 1,149 1,022 0.0 0.0   EBITDA   -180 312 67.2 120 164 90.7 0.0 0.0   EBIT   -180 298 53.7 107 151 90.7 0.0 0.0   Pre-tax profit (PTP)   -183.0 248.0 39.0 79.5 13.6 65.7 0.0 0.0   Net earnings   -183.0 226.7 27.9 64.8 -17.9 42.8 0.0 0.0   Pre-tax profit without non-rec. items   -183 248 39.0 79.5 13.6 65.7 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Tangible assets total   0.0 40.5 27.0 13.5 0.0 0.0 0.0 0.0   Shareholders equity total   -180 -43.3 -15.3 49.5 31.6 74.4 34.4 34.4   Interest-bearing liabilities   0.0 0.0 39.7 257 12.8 0.0 0.0 0.0   Balance sheet total (assets)   479 740 643 1,439 2,072 2,733 34.4 34.4   Net Debt   -48.3 -64.3 -60.3 257 -692 -887 -34.4 -34.4     See the entire balance sheet 1000.0 Volume  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   223 539 908 1,184 1,149 1,022 0.0 0.0   Gross profit growth   0.0% 141.5% 68.4% 30.4% -3.0% -11.0% -100.0% 0.0%   Employees   2 2 2 2 2 2 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   479 740 643 1,439 2,072 2,733 34 34   Balance sheet change%   0.0% 54.4% -13.2% 123.9% 43.9% 31.9% -98.7% 0.0%   Added value   -180.3 311.7 67.2 120.2 164.3 90.7 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 27 -27 -27 -27 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -1.0 1.0 2.0 3.0 4.0 5.0 0.0 0.0   1000.0 Profitability  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   -80.8% 55.3% 5.9% 9.0% 13.1% 8.9% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -27.0% 42.2% 7.5% 10.6% 8.5% 3.9% 0.0% 0.0%   ROI %   0.0% 0.0% 271.0% 64.5% 85.3% 156.2% 0.0% 0.0%   ROE %   -38.2% 37.2% 4.0% 18.7% -44.2% 80.8% 0.0% 0.0%   1000.0 Solidity  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Equity ratio %   -31.6% -5.5% -2.3% 3.4% 1.5% 2.7% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   26.8% -20.6% -89.8% 213.7% -421.3% -978.8% 0.0% 0.0%   Gearing %   0.0% 0.0% -259.0% 518.8% 40.5% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 74.4% 21.7% 100.8% 423.9% 0.0% 0.0%   1000.0 Liquidity  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Quick Ratio   0.5 0.5 0.5 0.6 0.7 0.9 0.0 0.0   Current Ratio   0.7 0.9 0.9 1.0 1.0 1.0 0.0 0.0   Cash and cash equivalent   48.3 64.3 100.0 0.0 705.1 887.3 0.0 0.0   1000.0 Capital use efficiency  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -185.3 -89.1 -47.7 -9.3 26.1 68.7 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   -90 156 34 60 82 45 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   -90 156 34 60 82 45 0 0   EBIT / employee   -90 149 27 53 75 45 0 0   Net earnings / employee   -92 113 14 32 -9 21 0 0